Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
National Institutes of Health (NIH)
Direct costs are limited to $450,000 over a 3-year project period, with no more than $225,000 in direct costs allowed in any single year.
To encourage research grant applications on the development and testing of behavioral and integrative treatments for substance misuse and dependence.
Researchers in the field of substance misuse and dependence treatment.
Individuals suffering from substance use disorders.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
Nonprofits must have or not have 501(c)(3) status with the IRS.
Foreign organizations are eligible to apply.
Organizations from the U.S. and non-domestic (non-U.S.) entities can apply.
Focus on behavioral and integrative treatment development for substance misuse and dependence.
Stage I research is supported, including intervention generation, refinement, and pilot testing.
Direct costs are limited to $450,000 over a 3-year project period.
No matching fund requirements are specified.
Application due date is May 7, 2025.
Open date for submissions is January 16, 2025.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated for scientific and technical merit through the NIH peer review system.
Applications will undergo a scientific peer review and will receive a written critique.
Scientific and technical merit of the proposed project will be considered.
Applications that include alcohol use disorder as a primary outcome will be considered non-responsive.
Applicants must ensure compliance with all application instructions to avoid delays or non-acceptance.
Research that incorporates innovative technologies and methodologies is encouraged.
Strong emphasis on innovative approaches may provide a competitive edge.
Demonstrating a clear understanding of behavioral intervention mechanisms.
Submitting applications that do not comply with the specified guidelines.
Engage with community settings for pilot testing to enhance real-world applicability.
Highlight innovative aspects of the proposed interventions to stand out in the review process.